# Chase Therapeutics Corp: Form D filings

Chase Therapeutics Corp, a pharmaceuticals company in Washington, DC, filed 2 Form D notices with the SEC between 2017 and 2018. The latest, on August 28, 2018, reports $4 million sold of a $4 million offering to 3 investors.

Find out what Chase Therapeutics Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Chase%20Therapeutics%20Corp%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Chase%20Therapeutics%20Corp&page=%2Fdata%2Fform-d%2Fcompany%2Fchase-therapeutics-corp-1723805)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Chase%20Therapeutics%20Corp%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Chase%20Therapeutics%20Corp&page=%2Fdata%2Fform-d%2Fcompany%2Fchase-therapeutics-corp-1723805)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in District of Columbia](https://specstream.ai/data/form-d/state/district-of-columbia): 247 rows, by operating companies, filed since November 1, 2024, $12.35, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/district-of-columbia
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1825 K STREET NW, SUITE 510, Washington, DC, 20006
- Phone: (202) 223-7002
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2017
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1723805

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Aug 28, 2018 | New notice | $4,000,000 | $4,000,000 | $0 | 3 | Aug 21, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1723805/000172380518000001/0001723805-18-000001-index.htm) |
| Nov 29, 2017 | New notice | $1,300,000 | $1,300,000 | $0 | 1 | Nov 17, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1723805/000172380517000001/0001723805-17-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Richard P. Dulik | Executive Officer |  |
| Kathleen N. Clarence-Smith | Director |  |
| Karoly P. Nikolich | Director |  |
| John P. Reher | Director |  |
| Thomas N. Chase | Executive Officer, Director |  |

[Every Form D from the week of Aug 27, 2018](https://specstream.ai/data/form-d/week/2018-08-27) · [All recent filings in District of Columbia](https://specstream.ai/data/form-d/state/district-of-columbia) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Chase Therapeutics Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).